Sector Gamma As Sage Therapeutics, Inc. Transaction History

Sector Gamma As

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$32.28 - $43.27 $89,738 - $120,290	-2,780 Reduced 2.35%	115,696 $4.53 Million
Q1 2022 May 06, 2022	BUY	$30.71 - $45.71 $601,056 - $894,636	19,572 Added 19.79%	118,476 $3.92 Million
Q4 2021 Feb 08, 2022	SELL	$37.06 - $47.11 $439,642 - $558,865	-11,863 Reduced 10.71%	98,904 $4.21 Million
Q3 2021 Oct 29, 2021	BUY	$40.26 - $57.37 $806,367 - $1.15 Million	20,029 Added 22.07%	110,767 $4.91 Million
Q2 2021 Aug 04, 2021	BUY	$54.88 - $79.29 $4.98 Million - $7.19 Million	90,738 New	90,738 $5.16 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.